AJP - Heart AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H539-H548, 2007. First published August 25, 2006; doi:10.1152/ajpheart.00640.2006
0363-6135/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Videos
Right arrow All Versions of this Article:
292/1/H539    most recent
00640.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, M.
Right arrow Articles by Kodama, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, M.
Right arrow Articles by Kodama, I.

Mechanisms of destabilization and early termination of spiral wave reentry in the ventricle by a class III antiarrhythmic agent, nifekalant

Masatoshi Yamazaki,1,* Haruo Honjo,1,* Harumichi Nakagawa,1 Yuko S. Ishiguro,1 Yusuke Okuno,1 Mari Amino,2 Ichiro Sakuma,3 Kaichiro Kamiya,1 and Itsuo Kodama1

1Research Institute of Environmental Medicine, Nagoya University, Nagoya; 2Department of Cardiology, Tokai University School of Medicine, Isehara; and 3Graduate School of Technology, The University of Tokyo, Tokyo, Japan

Submitted 15 June 2006 ; accepted in final form 18 August 2006


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Nifekalant (NF) is a novel class III antiarrhythmic agent that is effective in preventing life-threatening ventricular tachycardia/fibrillation (VT/VF). We investigated mechanisms of destabilization and early termination of spiral-type reentrant VT by NF in a two-dimensional subepicardial myocardial layer of Langendorff-perfused rabbit hearts (n = 21) using a high-resolution optical action potential mapping system. During basic stimulation, NF (0.1 µM) caused uniform prolongation of action potential duration (APD) without affecting conduction velocity and an increase of APD restitution slope. VTs induced by direct current stimulation in the presence of NF were of shorter duration (VTs > 30 s: 2/54 NF vs. 19/93 control). During VTs in control (with visible rotors), the wave front chased its own tail with a certain distance (repolarized zone), and they seldom met each other. The average number of phase singularity (PS) points was 1.31 ± 0.14 per 665 ms (n = 7). In the presence of NF, the wave front frequently encountered its own tail, causing a transient breakup of the spiral wave or sudden movement of the rotation center (spatial jump of PS). The average number of PS was increased to 1.63 ± 0.22 per 665 ms (n = 7, P < 0.05) after NF. The mode of spontaneous termination of rotors in control was in most cases (9/10, 90.0%) the result of mutual annihilation of counterrotating wave fronts. With NF, rotors frequently terminated by wave front collision with the atrioventricular groove (12/19, 63.2%) or by trapping the spiral tip in a refractory zone (7/19, 36.8%). Destabilization and early termination of spiral wave reentry induced by NF are the result of a limited proportion of excitable tissue after modulation of repolarization.

potassium channel blocker; optical mapping; ventricular tachycardia


VENTRICULAR TACHYCARDIA/FIBRILLATION (VT/VF) is the major cause of sudden cardiac death. It is generally believed that regardless of the initiating event, spiral- or vortex-type reentrant activity rotating around a functional obstacle (rotor) is the major organization center of VT/VF (3, 22, 2527). Pharmacological regulation of such rotors is therefore the central task to be achieved for efficient prevention of sudden arrhythmic death (8, 22, 25, 26). Nifekalant hydrochloride (NF) is a new class III antiarrhythmic drug developed in Japan that causes dose-dependent prolongation of action potential duration (APD) in both atrial and ventricular muscle, mainly by reducing the rapid component of the delayed rectifier K+ current (IKr) (12, 16, 17), and at higher concentrations, NF has an inhibitory effect on other voltage- and ligand-gated K+ currents (12, 16). APD prolongation by pharmacological blockade of IKr renders a certain proarrhythmic propensity known as drug-induced QT prolongation and torsades de pointes, and this potential risk limits the use of class III antiarrhythmic drugs (20). In experimental animals, however, NF has been shown to prevent VT/VF after acute myocardial infarction without compromising hemodynamics (9) and to improve electrical defibrillation efficacy (14). Several clinical studies have shown the usefulness of intravenous NF in the treatment of patients with recurrent VT/VF that is resistant to other antiarrhythmic drugs and direct current (DC) shocks (15, 16).

In a recent optical mapping study to examine the combined effects of NF and lidocaine in a two-dimensional (2D) subepicardial layer of rabbit ventricular myocardium, we have demonstrated that NF (0.5 µM) alone prolongs VT cycle length and causes its early termination in association with destabilization of the spiral wave dynamics (prolongation of functional block line, frequent local conduction block, and extensive meandering) (1). Preliminary experiments with NF at a lower concentration (0.1 µM) also showed analogous modification of spiral wave reentry (10). On the basis of these observations, we speculated that the NF-induced destabilization of spiral wave reentry may be the result of repolarization delay leading to more frequent wave front-tail interactions, but the issue remains to be substantiated. The mechanism of early VT termination was unclear. The present study was designed to clarity the points in similar 2D rabbit ventricular myocardial tissue preparations. Newly developed software to visualize the wave front and tail of optical action potential signals was employed to analyze their interaction. A phase-mapping method was used to quantify the destabilization and to elucidate the mode of termination of rotors. The results revealed that the wave front during VTs in the presence of NF does frequently encounter its own tail, giving rise to transient breakup of spiral wave or sudden movement of the rotation center, and that early VT termination with NF is the result of either wave front collision with the atrioventricular groove or trapping of the spiral tip in a refractory zone.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Experimental preparations. The protocol was approved by the Institutional Animal Care and Use Committee at Nagoya University. Experiments were performed in vitro on hearts obtained from Japanese White rabbits of both sexes weighing 1.7–2.0 kg. The experimental procedure was described previously in detail (1). In brief, rabbits were anesthetized with pentobarbital sodium (10–15 mg/kg), and the hearts were rapidly removed. The isolated hearts were continuously perfused on a Langendorff apparatus with modified Krebs-Ringer solution equilibrated with 95% O2-5% CO2 to maintain pH 7.4 (37°C). Complete atrioventricular block was produced by ligation of the His bundle. We created a 2D epicardial layer of ventricular myocardium by performing a cryoprocedure (1, 10). This model is similar to that reported by Schalij et al. (23) and has an advantage over use of the intact three-dimensional heart to visualize the spiral wave reentry on the epicardial surface. At the end of the experiment, the heart was stained with 2,3,5-triphenyltetrazolium chloride (TTC) and sectioned parallel to the atrioventricular groove, from base to apex, at 2-mm intervals. The surviving myocardium, which was stained deeply with TTC (reservation of dehydrogenase activity), was 1.0 ± 0.2 mm thick (10 hearts).

High-resolution optical mapping. The optical mapping system used in this study was described previously (1). After endocardial freezing, the hearts were stained with a voltage-sensitive dye, di-4-ANEPPS. To minimize motion artifacts, we added 15 mM 2,3-butanedione monoxime (BDM) unless otherwise specified. Bipolar electrograms were recorded through widely spaced electrodes, one at the apex of the left ventricle and the other at the lateral wall of the right ventricle, to monitor the whole ventricular excitations. The signals were filtered from 15 to 1,000 Hz and digitized at 1,000 Hz.

The hearts were illuminated with bluish light-emitting diodes; the emitted fluorescence was recorded with a solid-state image-sensing digital video camera (Fastcam-Ultima 40K; Photron) to acquire 8-bit gray scale images from 256 x 256 sites simultaneously at a speed of 750 frames/s. The images covered the anterolateral surface of the left ventricle and part of the anterior surface of the right ventricle. Each acquisition lasted 10.9 s.

To reveal the signal, we subtracted the background fluorescence from each frame and applied low-pass spatial filtering. The fluorescence signals were inverted and then spatially averaged to reduce noise. Spatial resolution after the low-pass filtering was 0.36–0.48 mm. Isochrone maps were generated from the filtered image. Action potential configuration was analyzed after the application of a five-point median filter to the spatially averaged data (13), and then the data were normalized to the range of the maximum and the minimum values in the respective 1,000-frame sample. A time point at 10% depolarization in the upstroke phase and a time point at 90% repolarization in its repolarization phase were identified for each action potential signal, and their interval was measured as APD at 90% repolarization (APD90). The distribution of APD90 values in the recording area was displayed as a color gradient map with 1.33-ms steps, ranging from red (shortest) to blue (longest).

Wave front-tail dynamics during VT were visualized by connecting the 10% depolarization points in the action potential upstrokes as the wave front (red) in the recording area and by connecting the 90% repolarization points as the wave tail (green). We quantified the pattern of wave propagation during VT using the phase-mapping method described by Gray et al. (5). The fluorescence of each pixel at time t, F(t), was plotted against the fluorescence of the same pixel offset by a time interval {tau} = 25 frames. A cyclic return map of F(t) vs. F(t{tau}) was constructed, allowing a new parameter, phase {theta}(t), to be defined as the angle of the coordinate [F(t), F(t{tau})] around the mean fluorescence for that given pixel, with values between –{pi} and {pi}. After the transformation, a new phase {theta}(t) movie was produced that included all pixels, in which different phases of the action potential were represented by a continuous color gradient extending from red to purple. Phase singularity (PS) was defined as the point at which all phases converged.

Experimental protocols. Conduction velocity and APD90 were measured during constant (S1) stimulation at the center of the left ventricular free wall at basic cycle lengths (BCLs) of 180–800 ms. A monopolar electrode made of platinum wire was used for stimulation. The longitudinal (LD) and transverse directions (TD) of propagation were determined from the activation maps elicited by S1 stimulation (1). Conduction velocity was measured in a central 18 x 18-mm square around the stimulation site, since measurement in the outer periphery would have been hampered by the sharp curvature of the ventricular surface. Conduction velocities in LD and TD were calculated from the slope of a linear least-squares fit of the activation time plotted against the distance. Data from an area very close to the stimulation site (<2 mm) were excluded to minimize the virtual electrode polarization effects.

We used the dynamic pacing method (11) to characterize the APD restitution property. The center of the left ventricular free wall was initially paced at a BCL of 400 ms, and the BCL was progressively shortened in steps of 5–20 ms. A minimum of 30 stimuli were delivered at a given BCL. APD restitution at a site 5 mm from the stimulation site in TD was analyzed. The APD90 of the final paced action potential was measured at a BCL with no APD alternans. When APD alternans occurred at a shorter BCL, the pacing was interrupted twice to measure the APD90 of both long and short action potential. The BCL was shortened until either a 2:1 block or higher order periodicity occurred. The APD restitution curve was constructed by plotting APD90 against the preceding diastolic interval, and the curve was fitted to a single-exponential function (Origin 7.0; Microcal Software, Northampton, MA).

VTs resulting from spiral-type excitation were induced by modified cross-field stimulation. Eighteen S1 stimuli at a BCL of 400 ms were applied to the apex through a pair of contiguous bipolar electrodes. A 10-ms monophasic rectangular pulse of constant voltage (20 V) was generated by a DC power unit and was delivered from the unit through a 6,700-µF capacitor connected to a power MOS-FET switch. A pair of Ag-AgCl paddle electrodes (7 mm in diameter) were placed on the lateral surface of the left and right ventricles for the DC stimulation (S2) to induce electrical field roughly perpendicular to the S1 excitation from the apex to the base (modified cross-field stimulation). The S1-S2 coupling interval was varied at 10-ms steps to apply S2 during the vulnerable window of the final S1 excitation.

Data were obtained before (baseline) and 20–30 min after application of 0.1 µM NF (Nihon Schering, Osaka, Japan). All the experiments were completed within 120 min of perfusion, during which the conduction velocity, APD90, and APD restitution were unchanged (see Supplemental Table 1; the online version of this article contains supplemental data). We confirmed in pilot experiments of four rabbit hearts that the effects of NF (0.1 µM) on the action potential configuration reached a steady state at ~30 min (see Supplemental Table 2). At the end of experiment, the tissues were fixed in 15% formalin and sectioned parallel to the epicardium at a 8-µm interval. The sections were stained with hematoxylin and eosin to examine the fiber orientation in the mapped area.

Statistical analysis. Group data are expressed as means ± SD. Statistical comparisons were performed using two-way ANOVA with Tukey's test, t-test, or Mann-Whitney U-test when appropriate. Differences were considered significant when the probability value was <0.05.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Conduction velocity and action potential. Conduction properties and action potential configurations were examined in seven hearts during constant stimulation from a center of the left ventricular free wall at a wide range of BCLs (180–800 ms). The isochrones of activation front exhibited a smooth, symmetric, elliptical pattern; the long axis corresponded to the fiber orientation of subepicardial cardiac muscle. In the central 18 x 18-mm square, there was a linear correlation between activation times and distances in both LD and TD. Conduction velocity in the LD and TD under control conditions was 55.2 ± 4.3 and 23.1 ± 2.1 cm/s, respectively, at a BCL of 800 ms. The values decreased slightly at shorter BCLs and reached 42.4 ± 3.9 and 16.6 ± 0.8 cm/s, respectively, at a BCL of 180 ms. The anisotropic ratio of the velocity was 2.4 to 2.6. NF at 0.1 µM and caused no significant changes in these parameters.

Figure 1 A shows representative changes in APD in response to NF application. Action potential signals obtained from 16 sites covering an 18 x 18-mm square were superimposed. NF (0.1 µM) caused uniform prolongation of APD at all recording sites. Figure 1B summarizes the changes in APD90 (average of the values at the 16 sites). NF caused significant prolongation of APD90, and the prolongation was greater at longer BCLs. The dispersion of the APD90 values among the 16 recording sites was virtually unaffected (Fig. 1C).


Figure 1
View larger version (26K):
[in this window]
[in a new window]

 
Fig. 1. Action potential duration (APD) and its restitution. A, top: 16 data-sampling sites (white dots) for APD measurements covering an 18 x 18-mm area around the stimulation site (center of the anterior aspect of the left ventricular free wall). Bottom, superimposed action potential signal [at a basic cycle length (BCL) of 800 ms] recorded from the 16 sites before (control) and after application of 0.1 µM nifekalant (NF). B: APD at 90% repolarization (APD90) during constant stimulation (average of values at the 16 sites) at a BCL of 180–800 ms before (control) and after NF (means ± SD, n = 7). At a BCL of 180 ms, data are presented for long and short APD90, respectively, reflecting alternans. C: APD90 dispersion among the 16 sites at a BCL of 180–800 ms before (control) and after NF (means ± SD, n = 7). D: representative relationship between APD90 and BCL of dynamic pacing before (control) and after NF. E: relationship between APD90 and diastolic interval (same experiment as in D).

 
Figure 1, D and E, shows representative data for the APD restitution. The plots of APD90 against the diastolic intervals before and after NF (0.1 µM) both fitted single-exponential function well (Fig. 1E). The maximal slope after NF (0.90) was much greater than under the control conditions (0.55). The average of the maximum slope values in five hearts increased from 0.48 ± 0.20 in control to 0.70 ± 0.24 after NF (n = 5, P < 0.05). NF also enhanced the APD alternans at shorter BCLs; the maximum alternans amplitude was increased from 5.8 ± 2.2 ms in control to 12.5 ± 5.5 ms after NF (n = 5, P < 0.05).

VTs induced by modified cross-field stimulation. VTs were induced in 15 hearts by DC stimulation before (control) and after NF (0.1 µM) application. In controls, 74 of 93 VTs (79.6%) terminated spontaneously within 30 s (nonsustained), whereas the other 19 (20.4%) persisted >30 s (sustained). Forty-six (49.5%) of the 74 nonsustained VTs terminated within 5 s. Of the 54 VTs in the presence of NF, 52 VTs (96.2%) were nonsustained and the 2 other VTs (3.7%) were sustained. Forty-four (81.5%) of the 52 nonsustained VTs terminated within 5 s. Thus VTs induced in the presence of NF (0.1 µM) terminated earlier than in the control conditions. VT cycle length (VTCL) after NF was significantly longer than under the control conditions (188 ± 31 vs. 154 ± 16 ms, P < 0.05).

Optical images of excitation during VT were analyzed in nine hearts exhibiting visible rotors in the observation area under the control conditions as well as after NF. Figure 2 shows a representative experiment. The record under the control condition (Fig. 2A) was obtained 2 s after VT initiation (see Supplemental Movie 1). Clockwise rotation of wave fronts circulating around a line of functional block (~7 mm) with a VTCL of 141 ms can be seen in isochrone maps. The circuit was more or less stable for >10 s and exhibited minimal meandering. A bipolar electrogram obtained during the VT episode showed monomorphic ventricular excitations. Characteristic features of the action potential configuration around the circuit, which were reported previously (1, 10), are recognized; those include slower upstroke at sites close to the pivot points (sites b and d), faster upstroke at sites after passing through the pivot points (sites a and c), clear double potential at the center of functional block line (site e), and no isoelectric segments between action potential signals. The block lines (4–9 mm) run either parallel (~70%) or across (~30%) the fiber orientation. There was no obvious tissue damage or macroscopic structural discontinuity to anchor the reentrant pathway in a fixed position.


Figure 2
View larger version (55K):
[in this window]
[in a new window]

 
Fig. 2. Spiral wave excitations in the absence and presence of 0.1 µM NF. A: ventricular tachycardia (VT) with almost monomorphic configuration under control conditions. A bipolar electrogram obtained during the VT (top), an isochrone map (middle), and sequential records of 5 optical action potential signals (bottom) are shown. Isochrones are 5.33-ms intervals (green lines for earlier wave fronts and blue lines for later wave fronts). Clockwise rotation around a line of block (yellow) in the anterior left ventricular free wall was repeated at a cycle length (VTCL) of 136–141 ms. Optical action potential signals were obtained from 5 sites (a–e in the isochrone map). B: VT with polymorphic configuration after application of NF. A bipolar electrogram (top), isochrone map of beats 1–3 (middle), and sequential records of 6 optical action potential signals (bottom) are shown. Clockwise rotation around dual lines of block (yellow) changed their circuits in each excitation with a VTCL of 176–195 ms. Optical action potential signals were obtained from 6 sites (a–f) indicated at left (isochrone map of beat 1). Data in A and B are from the same heart.

 
Figure 2B shows the activation pattern during a short VT (lasting for 3 s) induced after application of NF (0.1 µM) (see Supplemental Movie 2). Rotors circulating around functional block lines were observed in isochrone maps during the three consecutive cycles, but their circuits changed dramatically in a beat-to-beat manner, with VTCLs varying from 176 to 195 ms. In beat 1, a wave front coming down from the base faced a long oblique functional block line (site b), giving rise to its extension toward the right margin. The wave, after turning around the right margin, was divided into dual circuits, one toward the base and another toward the apex and the left margin. The upper circuit showed a local conduction block (site e), causing a further extension of the upper block line to maintain the clockwise rotation. In beat 2, the clockwise rotation of different dual circuits was preserved; the upper circuit was around a long functional block line in a direction (along the fiber orientation) and configuration similar to those of beat 1, whereas the lower circuit was around an L-shaped functional block line (one half along and one half across the fiber orientation). In beat 3, the upper functional block line moved toward the posterior surface (visible line was shortened). On the other hand, the lower functional block line was largely prolonged, traversing the whole anterior surface. Isochrones in the observation area for beat 3 showed an almost single large clockwise rotation. The total length of visible functional block lines for the three beats was 23.7–35.2 mm. The rotor terminated spontaneously five cycles later. Bipolar electrograms obtained during the VT episode showed polymorphic torsades de pointes-like ventricular excitations. The action potential signals from the circuits showed a marked beat-to-beat variation that reflects complex meandering of rotors and frequent conduction block.

Qualitatively similar results were obtained in all nine hearts. Thus the characteristic effects of NF on the spiral wave dynamics (prolongation of functional block line, an increase in meandering of circuits, and earlier termination of rotation) (1) have been visualized clearly in experiments at a lower drug concentration (0.1 µM).

Wave front-tail interaction and phase singularity. The mechanisms of NF-induced modification of spiral wave reentry were investigated in terms of the wave front-tail interaction and the PS dynamics. Seven VT episodes with rotors visible in the observation area were analyzed for each before (control) and after application of NF. During VTs under the control conditions, the wave front chased its own tail with a certain distance between them (repolarized zone), and the wave fronts seldom met each other (Fig. 3A, top). The number of PS points in the phase maps was normally (>90%) 1 (a single rotor; Fig. 3A, bottom) and, rarely, increased to 2 for a short period (Fig. 3D). In the presence of NF (0.1 µM), the wave front frequently encountered its own tail, causing transient breakup of the spiral wave (Fig. 3B, top) or sudden movement of the organizational center of rotation to another site (Fig. 3C, top). In the phase maps, the former was recognized as an increase in PS from 1 to 3 (Fig. 3B, bottom), whereas the latter was recognized as a sudden jump in PS site (Fig. 3C, bottom). Figure 3D shows representative changes in PS number per 500 frames (665 ms) after application of NF. Pooled data are summarized in Fig. 3E; the average number of PS points during 500 frames (665 ms) was 1.13 ± 0.14 in the control and 1.63 ± 0.22 after NF (n = 7, P < 0.05).


Figure 3
View larger version (51K):
[in this window]
[in a new window]

 
Fig. 3. Wave break formation by wave front-tail interaction. A: wave front (red) chasing a wave tail (green) during VT in the control condition. The top and bottom images are snapshots of wave front-tail and corresponding phase maps, respectively. The wave front does not encounter the tail (no breakup). B: interaction of a wave front with a wave tail during VT after application of 0.1 µM NF, causing the transient breakup of a rotor. C: interaction of a wave front with a wave tail during VT after NF, causing a sudden movement of the organizational center to another site. Phase singularity points (PSs) are indicated by circles (black for clockwise rotation, white for counterclockwise rotation). D: number of PSs over 500 frames (665 ms) during VT before (top) and after NF (bottom) (from the same heart as in A–C). E: average number of PSs/500 frames (665 ms) before (control) and after NF (means ± SD, n = 7). *P < 0.05 vs. control.

 
Mode of spiral wave termination. The mode of spontaneous termination of spiral wave excitation was analyzed in 10 VT episodes in the absence of NF (control) and 19 VT episodes in the presence of NF. In the controls, most VTs (9/10, 90.0%) terminated as a result of mutual annihilation of counterrotating spiral waves. Figure 4 A shows representative experiments (see Supplemental Movie 3). Excitation patterns for the final beat of a VT episode are shown in four sequential phase maps (left). A pair of PS points with opposite chiralities constructing a figure eight reentry circuit was present in the lower region of the left ventricle (1,850 ms). The distance between the two PS points initially increased (1,850 to 1,935 ms) and then decreased (1,935 to 1,951 ms), culminating in mutual annihilation (1,961 ms). The trajectories of the 2 PS points plotted on space (x, y) and time axes are shown in the middle (red, clockwise; blue, counterclockwise). Action potential signals recorded from six sites in the figure eight reentry circuit (right) revealed conduction block at the central common pathway (site d). In the remaining control episode, the VT ended by extinction of a single rotor when it collided against the anatomic boundary (atrioventricular groove).


Figure 4
View larger version (51K):
[in this window]
[in a new window]

 
Fig. 4. Spiral wave reentry terminated by mutual annihilation and exit from the ventricles. A: spontaneous termination of VT in the absence of NF (control) as a result of mutual annihilation of counterrotating spiral waves (#). Left, 4 snapshots of phase maps of the final beat of a VT episode; PSs are indicated by circles (black for clockwise rotation, white for counterclockwise rotation). Middle, trajectories of the 2 PSs plotted on space (x, y) and time axes (red for clockwise rotation, blue for counterclockwise rotation). Right, optical action potential signals from 6 sites (a–f) indicated at left. B: spontaneous termination of VT in the presence of NF by exit of a rotor from the ventricles. Left, 4 snapshots of phase maps of the last beat; crosshatched bar at top of each frame indicates the atrioventricular groove, and red line indicates the trajectory of a PS. Middle, trajectory of a PS plotted on space (x, y) and time axes (blue wall at right indicates the atrioventricular groove). Right, optical action potential signals recorded from 5 sites (a–e) indicated at left.

 
In the presence of NF, 12/19 VTs (63.2%) terminated by rotor extinction after considerable meandering toward the anatomic boundary. Figure 4B shows an example (see Supplemental Movie 4). In the four sequential phase maps (left), a clockwise rotating PS initially moved a long distance from the upper right region to the right margin, then back toward the upper central region (1,282 to 1,382 ms), and was finally pushed out of the atrioventricular groove (1,463 to 1,490 ms). The trajectory of the PS plotted on space and time axes is shown in the middle (the blue wall at right indicates the atrioventricular groove), and action potential signals recorded from five sites in the meandering pathway are shown at right.

In the remaining seven VTs (36.8%) in the presence of NF, the rotors terminated by trapping the spiral tip in a region entirely surrounded by refractory tissue. Figure 5 shows a representative experiment. Isochrone and APD90 maps of three beats before termination are shown in Fig. 5A. In beat 1, activation from the left upper region turned around a short functional block line (yellow) in a clockwise direction. In beat 2, the clockwise rotation was maintained and associated with extension of the functional block line toward the central region. In beat 3, the wave front from the left upper region was blocked in the central region. Because this wave front (red dotted line) was entirely surrounded by a refractory zone, no offspring wavelets emerged, and the VT terminated. Action potential signal tracings from two sites (asterisks) revealed APD alternans during the VT cycles (Fig. 5B), with the longest APD90 of beat 3 (site a) preventing further rotation of the wave front. The APD maps of beat 3 visualized trapping of the entire spiral tip by the long APD90 zone. A similar enhancement of APD alternans preceding the spontaneous termination was observed in all seven VTs of this group. Figure 5C shows phase maps of the final beat (see Supplemental Movie 5). The PS of clockwise rotation shifted from the left upper region to the center and then disappeared. The trajectory of the PS plotted on space and time axes is shown in Fig. 5D.


Figure 5
View larger version (69K):
[in this window]
[in a new window]

 
Fig. 5. Spiral wave reentry termination by trapping the wave front. A: isochrone and APD90 maps of the final 3 beats of VT before spontaneous termination in the presence of NF. Isochrones are at 5.33-ms intervals (green lines for earlier wave fronts, blue lines for later wave fronts). The latest activation front is presented by a dotted red line, and the line of functional block is shown in yellow. APD90 in the recording area is represented by color gradients, ranging from red (shortest) to blue (longest). B: optical action potential signals recorded at 2 sites (sites a and b in A). Numbers at the bottom of each action potential indicate the APD90 (ms). C: snapshots of phase maps in the final beat. PS with clockwise rotation is indicated by a black circle. D: trajectory of the PS plotted on space (x, y) and time axes.

 
VTs induced in the absence of BDM. In three hearts, VTs were induced in the absence of BDM, and the effects of NF (0.1 µM) on the spiral wave dynamics were analyzed using phase maps. The results in each of the three hearts were essentially similar to those obtained in the presence of BDM. In controls, 27 of 32 VTs (84.4%) terminated spontaneously within 30 s (nonsustained), whereas the other 5 VTs (15.6%) persisted >30 s (sustained). Of these VTs, 26 (81.3%) terminated within 5 s. All 12 VTs (100%) in the presence of NF were nonsustained and terminated within 5 s.

A representative experiment is shown in Fig. 6. In the control conditions (Fig. 6A), a PS of counterclockwise rotation was present in the middle of the anterior surface of the left ventricle. A trajectory of the PS revealed that the rotor was more or less stable and exhibited moderate meandering (1,718–2,041 ms). After application of NF (Fig. 6B), a PS of clockwise rotation moved a long distance with a complex trajectory; from the right margin to the upper central region (895–942 ms), going back to the right margin, followed by a traverse in opposite direction toward the posterior surface. The PS reappeared on the anterior surface (left upper region), turned back toward the left upper corner (anatomical boundary), and terminated (1,127–1,250 ms). Action potential signals showed nearly uniform configuration in control (Fig. 6A) compared with marked beat-to-beat variation after NF (Fig. 6B).


Figure 6
View larger version (65K):
[in this window]
[in a new window]

 
Fig. 6. Effects of NF on the spiral wave reentry dynamics in the absence of 2,3-butanedione monoxime (BDM). A: 4 snapshots of phase maps during a VT episode in the control condition. B: 4 snapshots of phase maps at the end (spontaneous termination) of a VT episode after NF (0.1 µM). PSs are indicated by white and black circles (counterclockwise and clockwise rotation, respectively); PS trajectory is indicated by solid lines. Optical action potential signals recorded from a left upper region (asterisk) are shown at bottom.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The results of this study in a 2D ventricular myocardium with normal anisotropy have revealed that NF-induced delay and dynamic instability of ventricular repolarization causes frequent collision of spiral wave fronts with their own tails or anatomical boundaries, giving rise to breakup, sudden movement of PS, or extinction of rotors.

Action potential and conduction properties. In this study, we first examined the effects of 0.1 µM NF on the conduction velocity and APD under constant stimulation at a wider range of BCLs (180–800 ms) than in our previous study at 0.5 µM (BCLs 250 and 400 ms) (1). NF (0.1 µM) caused spatially uniform APD prolongation without affecting conduction velocities. The APD prolongation was significant even at a BCL of 180 ms, but it was greater at longer BCLs. The spatial dispersion of APD measured at 16 sites to cover an 18 x 18-mm square was unaffected by NF. NF increased the slope of the APD restitution curve, and the change was associated with an increase in APD alternans. All of these NF-induced alterations in the steady-state and dynamic electrophysiological properties of ventricular muscle can be ascribed to IKr blockade. In action potential clamp experiments, Hua and Gilmour (7) recently demonstrated that IKr contribute importantly to ventricular muscle repolarization during normal and high-frequency stimulation and that APD alternans is regulated substantially by time- and voltage-dependent activation and deactivation of IKr.

VTs of spiral wave reentry. In our 2D ventricular muscle tissue preparations of rabbit heart, spiral wave reentry rotating around functional block lines (single or double loops) can be induced by modified cross-field stimulation in the observation area in more than half (53–61%) of whole VT episodes under the control conditions (1, 10). The VTs induced are polymorphic during the initial several beats (1, 10) but become almost monomorphic during the subsequent beats. Microscopic structural discontinuities in association with anisotropic fiber orientation or epicardial blood vessels may provide a basis for this anchoring behavior.

VTs induced in the presence of NF (0.1 µM) are, consistent with our previous report with NF at 0.5 µM (1), characterized by longer cycle length, polymorphic configuration, and earlier termination than those observed in the controls. The optical images showed that these changes were associated with marked destabilization of rotors, which circulated around much longer and variable functional block lines formed by refractory wake of preceding excitations. We analyzed movies of wave front and wave tail during the rotations and found that a wave front in the presence of NF (0.1 µM) frequently encounters its own tail, resulting in breakup or sudden jump of organizational center of the rotation. The marked destabilization of rotors in the presence of NF cannot be ascribed to a APD restitution slope >1, since the maximum slope after NF, although increased, remained 0.7 on average. Other factors such as short-term cardiac memory, electronic currents, and unstable intracellular Ca2+ cycling also can affect wave stability and may have played a role in enhancing meander of the circuit. The enhanced meandering may have further facilitated the wave front-tail interactions through creation of Doppler-shifted short cycle length in front of moving phase singularities (4, 6).

Spiral wave reentry termination. Information on the effect of IKr block on the dynamics of spiral wave reentry in the ventricular myocardium is still limited. An analysis of computer model of isotropic 2D cardiac tissue showed discrepancies among investigators in the role of the delayed rectifier K+ current (IK) in the regulation of spiral wave dynamics. In their model, Beaumont and Jalife (2) showed that APD is significantly abbreviated (too short for IK activation) near the center of the rotation. Thus IK block prolongs APD only in the periphery and not close to the center. This leads to frequent wave front-tail interaction in the spiral arm without affecting the rotation period. Jalife and colleagues (2, 21) suggested that the inward rectifier K+ current (IK1) may play a much more important role than IK [IKr and IKs (slow component)] in regulation of spiral core dynamics. In their simulation using the phase 1 Luo-Rudy ventricular action potential model, on the other hand, Qu et al. (18) have shown that APD close to the spiral core is longer than in the periphery and that a substantial amount of IK is preserved at the rotation center. They demonstrated that reduction of IK conductance promotes meandering of the spiral core and that quasiperiodic meandering is converted to chaotic meandering that culminates in the breakup of rotors (18).

Our observations in the rabbit heart suggest that IKr plays an essential role in repolarization of the action potential not only in the arm but close to the core of spiral wave reentry. In the absence of NF (control), most spontaneous terminations of spiral-type excitations were the result of mutual annihilation of a pair of rotors with opposite chiralities. NF facilitated the spontaneous termination by two different mechanisms: extinction of rotor(s) after collision with the anatomic boundary, and trapping of the spiral tip in a region entirely surrounded by refractory tissue. The former mode is attributable to considerable meandering of the rotation center, whereas the latter is attributable to APD prolongation of the preceding excitation in association with increased APD alternans near the spiral tip. The latter mode of termination is similar to that reported by Beaumont and Jalife (2) in their 2D cardiac tissue model when sodium current inactivation was slowed in combination with APD prolongation or when the outward component of IK1 was reduced. In a recent theoretical study by Qu and Weiss (19), blockade of time-dependent K+ channel was shown to increase dynamic instability of rotors and to facilitate their self-termination. The present results validate their prediction.

Most of the modification of spiral wave dynamics induced by NF (0.1 µM) may be shared by other IKr blocking drugs, since much higher concentrations (5–100 µM) are required for NF to affect other voltage- and ligand-gated K+ currents (17). However, further experimental studies are required to elucidate the point.

Limitations. In this study using a 2D subepicardial layer of rabbit ventricular myocardium, NF-induced delay and instability of ventricular repolarization were shown to cause frequent collision of spiral wave fronts with their own tails or anatomical boundaries, giving rise to breakup or early extinction of rotors. Extending these results to 3D hearts, especially in larger animals including humans, is not straightforward. If there is sufficient tissue mass, the chance of spontaneous termination of rotors by wave front collision or trapping would be reduced, whereas the enhancement or rotor meander and wave instability may promote breakup in favor of transition from VT to VF. The greater structural discontinuities and functional heterogeneities in diseased hearts would also alter the spatial requirements of spontaneous rotor termination. Thus NF can be not only antiarrhythmic but also proarrhythmic. There are certain clinical reports (in Japanese) showing excessive QT prolongation and torsades de pointes induced by NF (0.1–0.3 mg/kg iv). Plasma concentrations at such therapeutic doses are comparable to the NF concentration (0.1 µM) employed in the present study (17). The proarrhythmia via rotor breakup might be dangerous, since it would promote VF generation and perpetuation. We used BDM as an excitation-contraction uncoupler that is known to alter ionic currents and to reduce the APD restitution slope (13). However, this does not seem to invalidate the present results, because the characteristic modification of the spiral wave dynamics by NF was preserved in the absence of BDM. We cannot completely neglect the potential photodynamic toxicity of the voltage-sensitive dye (di-4-ANEPPS), but this may not have significant effects on the electrophysiological properties of the preparations in our experimental conditions, because there were no time-dependent changes of conduction velocity and action potential configuration up to 120 min of control perfusion (see Supplemental Table 1). There are considerable species differences in the relative contribution of IKr to the repolarization of action potential in ventricular myocytes. Despite these limitations, the present results may provide a new perspective for future development of drugs to prevent sudden arrhythmic death.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This study was supported by Grant-in-Aid for Scientific Research (A) 14207034 from the Japan Society for the Promotion of Science and by the Health and Labor Science Research on Medical Devices for Analyzing, Supporting and Substituting the Function of Human Body from the Ministry of Health, Labor and Welfare of Japan (H15–17 Physi-001).


    FOOTNOTES
 

Address for reprint requests and other correspondence: I. Kodama, Dept. of Cardiovascular Research, Research Institute of Environmental Medicine, Nagoya Univ., Chikusa-ku, Nagoya 464-8601, Japan (e-mail: ikodama{at}riem.nagoya-u.ac.jp)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

* M. Yamazaki and H. Honjo contributed equally to this work. Back


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Amino M, Yamazaki M, Nakagawa H, Honjo H, Okuno Y, Yoshioka K, Tanabe T, Yasui K, Lee JK, Horiba M, Kamiya K, Kodama I. Combined effects of nifekalant and lidocaine on the spiral-type re-entry in a perfused 2-dimensional layer of rabbit ventricular myocardium. Circ J 65: 576–584, 2005.[CrossRef]
  2. Beaumont J, Jalife J. Rotors and spiral waves in two dimensions. In: Cardiac Electrophysiology: From Cell to Bedside (3rd ed.), edited by Zipes DP, Jalife J. Philadelphia, PA: Saunders, 2000, p. 327–335.
  3. Davidenko JM, Pertsov AM, Salomonsz R, Baxter WP, Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature 355: 349–351, 1992.[CrossRef][Medline]
  4. Fenton FH, Cherry EM, Hastings HM, Evans SJ. Multiple mechanisms of spiral wave breakup in a model of cardiac electrical activity. Chaos 12:852–892, 2002.[CrossRef][ISI][Medline]
  5. Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature 392: 75–78, 1998.[CrossRef][Medline]
  6. Gray RA, Jalife J, Panfilov AV, Baxter WT, Cabo C, Davidenko JM, Pertsov AM. Mechanisms of cardiac fibrillation. Science 270: 1222–1223, 1995.[Abstract/Free Full Text]
  7. Hua F, Gilmour RF Jr. Contribution of IKr to rate-dependent action potential dynamics in canine endocardium. Circ Res 94: 810–819, 2004.[Abstract/Free Full Text]
  8. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol 62: 25–50, 2000.[CrossRef][ISI][Medline]
  9. Kamiya J, Ishii M, Katakami T. Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia. Jpn J Pharmacol 58: 107–115, 1992.[Medline]
  10. Kodama I, Honjo H, Yamazaki M, Nakagawa H, Ishiguro Y, Okuno Y, Sakuma I, Kamiya K. Optical imaging of spiral waves: pharmacological modification of spiral-type excitation in a 2-dimensional layer of ventricular myocardium. J Electrocardiol 38: 126–130, 2005.[CrossRef][ISI][Medline]
  11. Koller ML, Riccio ML, Gilmour RF Jr. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am J Physiol Heart Circ Physiol 275: H1635–H1642, 1998.[Abstract/Free Full Text]
  12. Kushida S, Ogura T, Komuro I, Nakaya H. Inhibitory effect on the class III antiarrhythmic drug nifekalant on HERG channels: mode of action. Eur J Pharmacol 457: 19–27, 2002.[CrossRef][ISI][Medline]
  13. Lee MH, Lin SF, Ohara T, Omichi C, Okuyama Y, Chudin E, Garfinkel A, Weiss JN, Karagueuzian HS, Chen PS. Effects of diacetyl monoxime and cytochalasin D on ventricular fibrillation in swine right ventricles. Am J Physiol Heart Circ Physiol 280: H2686–H2696, 2001.
  14. Murakawa Y, Yamashita T, Kanese Y, Omata M. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation? J Am Coll Cardiol 29: 688–692, 1997.[Abstract]
  15. Myoishi M, Yasuda S, Miyazaki S, Ueno K, Morii I, Satomi K, Otsuka Y, Kawamura A, Kurita T, Kitamura S, Nonogi H. Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis. Circ J 67: 898–900, 2003.[CrossRef][ISI][Medline]
  16. Nakaya H, Tohse N, Takeda Y, Kanno M. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br J Pharmacol 109: 157–163, 1993.[ISI][Medline]
  17. Nakaya H, Uemura H. Electropharmacology of nifekalant, a new class III antiarrhythmic drug. Cardiovasc Drug Rev 16: 133–144, 1998.
  18. Qu Z, Xie F, Garfinkel A, Weiss JN. Origins of spiral wave meander and break in a two-dimensional cardiac tissue model. Ann Biomed Eng 28: 755–771, 2000.[CrossRef][ISI][Medline]
  19. Qu Z, Weiss JN. Effects of Na+ and K+ channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue. Am J Physiol Heart Circ Physiol 289: H1692–H1701, 2005.[Abstract/Free Full Text]
  20. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022, 2004.[Free Full Text]
  21. Samie FH, Berenfeld O, Anumonwo J, Mironov SF, Udassi S, Beaumont J, Taffet S, Pertsov AM, Jalife J. Rectification of the background potassium current. A determinant of rotor dynamics in ventricular fibrillation. Circ Res 89: 1216–1233, 2001.[Abstract/Free Full Text]
  22. Samie FH, Jalife J. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart. Cardiovasc Res 50: 242–250, 2001.[Abstract/Free Full Text]
  23. Schalij MJ, Lammers WJEP, Rensma PL, Allessie MA. Anisotropic conduction and reentry in perfused epicardium of rabbit ventricle. Am J Physiol Heart Circ Physiol 263: H1466–H1478, 1992.[Abstract/Free Full Text]
  24. Takenaka K, Yasuda S, Miyazaki S, Kurita T, Sutani Y, Morii I, Daikoku S, Kamakura S, Nonogi H. Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction. Jpn Circ J 65: 60–62, 2001.[CrossRef][Medline]
  25. Weiss JN, Garfinkel A, Karagueuzian HS, Qu Z, Chen PS. Chaos and the transition to ventricular fibrillation. A new approach to antiarrhythmic drug evaluation. Circulation 99: 2819–2826, 1999.
  26. Weiss JN, Qu Z, Chen PS, Lin SF, Karagueuzian HS, Hayashi H, Garfinkel A, Karma A. The dynamics of cardiac fibrillation. Circulation 112: 1232–1240, 2005.
  27. Winfree AT. Electrical turbulence in three-dimensional heart muscle. Science 266: 1003–1006, 1994.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Harada, H. Honjo, M. Yamazaki, H. Nakagawa, Y. S. Ishiguro, Y. Okuno, T. Ashihara, I. Sakuma, K. Kamiya, and I. Kodama
Moderate hypothermia increases the chance of spiral wave collision in favor of self-termination of ventricular tachycardia/fibrillation
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1896 - H1905.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Sato, T. Ohkusa, H. Honjo, S. Suzuki, M.-a. Yoshida, Y. S. Ishiguro, H. Nakagawa, M. Yamazaki, M. Yano, I. Kodama, et al.
Altered expression of connexin43 contributes to the arrhythmogenic substrate during the development of heart failure in cardiomyopathic hamster
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1164 - H1173.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Videos
Right arrow All Versions of this Article:
292/1/H539    most recent
00640.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, M.
Right arrow Articles by Kodama, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, M.
Right arrow Articles by Kodama, I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.